ECCO Topical Review: Refractory Inflammatory Bowel Disease

44Citations
Citations of this article
81Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Inflammatory bowel disease is a chronic disease with variable degrees of extent, severity, and activity. A proportion of patients will have disease that is refractory to licensed therapies, resulting in significant impairment in quality of life. The treatment of these patients involves a systematic approach by the entire multidisciplinary team, with particular consideration given to medical options including unlicensed therapies, surgical interventions, and dietetic and psychological support. The purpose of this review is to guide clinicians through this process and provide an accurate summary of the available evidence for different strategies.

Cite

CITATION STYLE

APA

Raine, T., Verstockt, B., Kopylov, U., Karmiris, K., Goldberg, R., Atreya, R., … Cullen, G. (2021, October 1). ECCO Topical Review: Refractory Inflammatory Bowel Disease. Journal of Crohn’s and Colitis. Oxford University Press. https://doi.org/10.1093/ecco-jcc/jjab112

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free